Latest Breaking News On - Herbert loong - Page 1 : comparemela.com

Luye Pharma's Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao

ASPIRE For Lung Cancer Consortium Launched To Address The Growing Burden Of Lung Cancer In Asia-Pacific

ASPIRE for Lung Cancer Consortium Launched to Address the Growing Burden of Lung Cancer in Asia-Pacific

SINGAPORE - Media OutReach Newswire - 4 February 2024 - On World Cancer Day, a consortium called the Asia Pacific Policy Review and Engagement for Lung Cancer, known as ASPIRE, officially launches to tackle lung cancer, one of the leading causes of cancer deaths in the Asia-Pacific region. The group will work with governments, agencies, NGOs and patient groups to.

ESMO: Lilly's Retevmo drives major benefits in lung, thyroid cancers as Roche bows out of competition

Oncologist Herbert Loong Joins George Clinical Scientific Leadership

Oncologist Herbert Loong Joins George Clinical Scientific Leadership News provided by Share this article Share this article OVERLAND PARK, Kan., Jan. 18, 2021 /PRNewswire/  Herbert Loong, MBBS, PDipMDPath, MRCP (UK), FRCP Edin, FHKCP, FHKAM (Medicine), an oncologist and clinical researcher based in Hong Kong, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization. Dr. Loong holds conjoint appointments of Clinical Assistant Professor in the department of clinical oncology and Deputy Medical Director of the Phase 1 Clinical Trials Center of The Chinese University of Hong Kong. He is also the current and founding convenor of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team.